Flu Vaccine Shows Promise for Reducing Risk of Influenza-Associated Atrial Fibrillation
According to New Evidence Reported in HeartRhythm
According to New Evidence Reported in HeartRhythm
Philadelphia, PA February 2, 2016
Influenza is significantly associated with an increased risk of new-onset atrial fibrillation, which could be reduced through influenza vaccination, according to new findings reported HeartRhythm.
Atrial fibrillation (AF) is a heart condition that causes an irregular and often abnormally fast heart rate and is the most common cardiac arrhythmia seen in clinical practice, accounting for frequent hospitalizations, hemodynamic abnormalities, and blood clots. It is associated with a five-fold increased risk of stroke.
Researchers in Taiwan investigated whether influenza infection is a risk factor for AF and whether influenza vaccination could reduce the risk. “Although the precise mechanisms of AF are not well understood, accumulating evidence indicates that inflammation and the autonomic nervous system are involved in the development of AF,” explained lead investigators Tze-Fan Chao, MD, and Su-Jung Chen, MD, of Taipei Veterans General Hospital, Taiwan.
The researchers identified over 11,000 patients with newly diagnosed AF from the Taiwan National Health Insurance Research Database records for 2000 to 2010. Each patient was matched with four control patients without AF who were enrolled on the same date, bringing the total number of patients in the study to approximately 57,000.
Patients who did not get influenza and had not been vaccinated served as a reference group. Data analysis revealed that patients diagnosed with an influenza infection and who had not been vaccinated had an 18% higher risk of AF than patients in the reference group. Patients who had been vaccinated and experienced influenza had a similar risk of AF to patients in the reference group. Influenza vaccination was consistently associated with a lower risk of AF in different groups of patients.
“According to the findings presented here, the possibility of AF should be kept in mind when patients with influenza infection complain of palpitations or experience ischemic stroke,” noted the investigators. “Influenza vaccination should be encouraged for patients, especially those who have a high risk of atrial fibrillation, to try to prevent the occurrence of atrial fibrillation and subsequent stroke. However, a further prospective study is necessary to confirm our findings.”
“Although the flu vaccine is already recommended for many patient groups, this study suggests that there are even more potential public health benefits of the vaccine,” commented Nishant Verma, MD, MPH, and Bradley P. Knight, MD, FHRS, of the Division of Cardiology, Department of Medicine at Northwestern University, Chicago, in an accompanying editorial. “The results of this study beg the question as to whether the acute treatment of the influenza infection itself, or addressing the inflammatory response associated with infection, may help prevent secondary episodes of AF. Beyond the prospective trial mentioned by the authors, we look forward to future studies into these and other areas that may help confirm and validate the observed findings.”
Notes for Editors
“The Association between Influenza Infection, Vaccination and Atrial Fibrillation: A Nationwide Case-Control Study,” by Ting-Yung Chang; Tze-Fan Chao; Chia-Jen Liu; Su-Jung Chen; Fa-Po Chung; Jo-Nan Liao; Ta-Chuan Tuan; Tzeng-Ji Chen; and Shih-Ann Chen (DOI: http://dx.doi.org/10.1016/j.hrthm.2016.01.026).
“The Flu and Atrial Fibrillation: Nothing to Sneeze At,” byNishant Verma, MD, MPH, and Bradley P. Knight, MD, FHRS (DOI: http://dx.doi.org/10.1016/j.hrthm.2016.01.025).
This article and accompanying editorial appear online in HeartRhythm, published by Elsevier.
Full text of the article and editorial is available to credentialed journalists upon request. Contact Jane Grochowski at+1 406 542 8397 or firstname.lastname@example.org to obtain copies. Journalists who wish to interview the authors should contact Dr. Tze-Fan Chao at +886 2 2875 7156 or email@example.com. Dr. Bradley P. Knight may be reached for comment via Kara Spak, Specialist, Media Relations, Northwestern Memorial HealthCare, at +1 312 926 0755 (office), +1 312 593 0596 (cell), or firstname.lastname@example.org.
About HeartRhythm HeartRhythm, the official Journal of the Heart Rhythm Society (www.hrsonline.org) and the Cardiac Electrophysiology Society (www.cardiaceps.org), is a unique journal for fundamental discovery and clinical applicability. It integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of the EP community. www.heartrhythmjournal.com
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+1 406 542 8397